Careers  |  Sign In  |  Register  |   Twitter

Latest in Infectious Diseases

According to Reuters, the experimental Ebola vaccine co-developed by Merck and NewLink did not have any serious side effects in early trials. Since early November, 34 volunteers have been injected with the VSV-EBOV vaccine, with reported side effects limited to mild fever. In addition to Merck and NewLink,...
60 years ago, the Salk polio vaccine was tested in hundreds of thousands of American children in a nationwide trial that demanded the assistance of 325,000 doctors, nurses, educators and private citizens, and no monetary support from federal grants or pharmaceutical companies. CBS News reports that 1.8...
According to Reuters, Merck & Co. will buy worldwide commercial rights to rVSV-EBOV, the experimental Ebola vaccine produced by NewLink Genetics Corp. The drug, which was initially developed by the Public Health Agency of Canada, is being tested by the National Institutes of Health with results of a...